Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Common Equity (2016 - 2025)

Eastman Chemical (EMN) has disclosed Common Equity for 17 consecutive years, with $6.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 3.16% year-over-year to $6.0 billion, compared with a TTM value of $6.0 billion through Dec 2025, up 3.16%, and an annual FY2025 reading of $6.0 billion, up 3.16% over the prior year.
  • Common Equity was $6.0 billion for Q4 2025 at Eastman Chemical, up from $5.8 billion in the prior quarter.
  • Across five years, Common Equity topped out at $6.3 billion in Q1 2021 and bottomed at $5.2 billion in Q4 2022.
  • Average Common Equity over 5 years is $5.7 billion, with a median of $5.7 billion recorded in 2024.
  • The sharpest move saw Common Equity fell 11.96% in 2023, then grew 6.58% in 2024.
  • Year by year, Common Equity stood at $5.8 billion in 2021, then decreased by 9.54% to $5.2 billion in 2022, then increased by 5.61% to $5.5 billion in 2023, then rose by 5.82% to $5.9 billion in 2024, then increased by 3.16% to $6.0 billion in 2025.
  • Business Quant data shows Common Equity for EMN at $6.0 billion in Q4 2025, $5.8 billion in Q3 2025, and $5.9 billion in Q2 2025.